Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Rockwell Automation (ROK) vs Revvity Inc (RVTY) Price & Performance

Rockwell AutomationTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Rockwell Automation vs Revvity Inc — how do they compare? Rockwell Automation trades at $433.08 (market cap $48.21B), while Revvity Inc trades at $154.78 (market cap $16.98B). The key difference: Rockwell Automation is far larger — about 2.8× Revvity Inc's market cap, and Rockwell Automation pays the higher dividend (1.27%). Which is the better fit depends on your goals — on Pluang, investors hold Rockwell Automation for 74 Days and Revvity Inc for 12 Days on average.

ROKRVTY
Market Cap
$48.21B$16.98B
Volume
953,3421,456,900
Sector
IndustrialsHealth
52-Week High
$495.08$157.36
52-Week Low
$333.75$82.26
Typical Hold Time
74 Days12 Days
Enterprise Value
$51.34B$19.30B
Dividend Yield
1.27%0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rockwell Automation

Rockwell Automation (ROK) trades at $432.61, down 2.1% on the day, with a bearish technical signal. The stock shows strong profitability with a 13.38% net income margin and 34.47% ROE, but trades at elevated valuation multiples including a P/E of 40.65. Recent earnings have consistently beaten estimates, and the company maintains a solid cash flow profile. Positive news highlights its leadership in industrial automation and digital transformation initiatives.

The outlook is mixed: analyst consensus is a Buy with a $489.89 price target, implying potential upside, but high valuation and near-term technical weakness pose risks. Key catalysts include continued execution on automation demand trends, while risks involve macroeconomic sensitivity and competitive pressures.

Revvity Inc

Revvity (RVTY) trades at $154.33, up 0.48% on the day and near its 52-week high of $158.28. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and positive analyst upgrades reflect solid fundamentals. Key developments include the launch of a new Type 1 diabetes screening kit in Europe and the acquisition of Human Cell Design to bolster metabolic disease research, signaling growth in diagnostics and life sciences.

The outlook remains positive given consistent earnings outperformance and strategic expansions, though rich valuation multiples pose a risk if growth moderates. Investors face near-term headwinds from margin pressures in China and elevated P/E ratios, but institutional accumulation and a lack of sell ratings support a constructive bias for long-term holders.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ROK
0% Buy100% Sell
Avg holding period · 74 Days
RVTY
0% Buy100% Sell
Avg holding period · 12 Days

Top news

Latest headlines on both assets

About Rockwell Automation

Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.

Read more on ROK →

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY →